LEIOMYOSARCOMA METASTATIC

Clinical trials for LEIOMYOSARCOMA METASTATIC explained in plain language.

Never miss a new study

Get alerted when new LEIOMYOSARCOMA METASTATIC trials appear

Sign up with your email to follow new studies for LEIOMYOSARCOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Two-Drug attack on Tough-to-Treat sarcoma

Disease control Ongoing

This study is testing whether adding a newer drug, lurbinectedin, to a standard chemotherapy (doxorubicin) works better for treating advanced soft-tissue sarcoma. The first part checks the safety and best dose of the combination. The second part directly compares the new combinat…

Matched conditions: LEIOMYOSARCOMA METASTATIC

Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

LEIOMYOSARCOMA METASTATIC

Get alerted when new LEIOMYOSARCOMA METASTATIC trials appear

New Two-Drug attack on Tough-to-Treat sarcoma